All In Biotech

Drug Trial Radar · NCT04944706

Efficacy and Safety of Qishenyiqi Dripping Pills for Treating Chronic Heart Failure With Preserved Ejection Fraction

Efficacy and Safety of Qishenyiqi Dripping Pills for Treating Chronic Heart Failure With Preserved Ejection Fraction: a Randomized, Double-blind, Basic-treatment-loading, Placebo-controlled, Multicenter Phase Ⅱ Clinical Trial

Last checked: Nov 20, 2026Latest source record: Oct 23, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 225 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

225

Actual

Start

Oct 18, 2021

Primary completion

Jan 22, 2025

Study completion Jan 22, 2025

Sponsor

Sponsor type
Industry
First posted
Jun 30, 2021

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Main objective: To evaluate the efficacy, safety and clinical dose exploration of Qishen Yiqi dripping pills in the treatment of chronic heart failure with preserved ejection fraction.

Conditions

  • Chronic Heart Failure With Preserved Ejection Fraction

Interventions

  • Qishen Yiqi dripping pills 2 bags/time + Qishen Yiqi dripping pills placebo 2 bags/timeDrug

    Take 3 times a day after meals,24 weeks

  • Qishen Yiqi dripping pills 4 bags/timeDrug

    Take 3 times a day after meals,24 weeks

  • Qishen Yiqi dripping pills placebo 4 bags/timeDrug

    Take 3 times a day after meals,24 weeks

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. 6-Minutes-Walking-Test (6MWT)Time frame: Baseline to weeks 12 and 24

Locations

16 sites in 1 country. Site status is shown where the registry gives one.

  • The First Affiliated Hospital of Bengbu Medical College

    Bengbu, Anhui, China

  • Beijing Hospital

    Beijing, Beijing Municipality, China

  • Peking Union Medical College Hospital, Chinese Academy of Medical Sciences

    Beijing, Beijing Municipality, China

  • Xuanwu Hospital Capital Medical University

    Beijing, Beijing Municipality, China

  • Peking University People's Hospital

    Beijing, Bejing, China

  • The First Affiliated Hospital of Chongqing Medical University

    Chongqing, Chongqing Municipality, China

  • Hebei General Hospital

    Shijiazhuang, Hebei, China

  • The Third Affiliated Hospital of Xinxiang Medical College

    Xinxiang, Henan, China

  • The third Xiangya Hospital of Central South University

    Changsha, Hunan, China

  • Jiangsu Province Hospital

    Nanjing, Jiangsu, China

  • Zhongda Hospital Southeast University

    Nanjing, Jiangsu, China

  • China Japan Union Hospital of Jilin University

    Changchun, Jilin, China

  • The Affiliated Hospital of Inner Mongolia Medical University

    Hohhot, Nei Monggol Autonomous Region, China

  • First Hospital of Shanxi Medical University

    Taiyuan, Shanxi, China

  • The Second Affiliated Hospital Of Xi'an Jiaotong University

    Xi’an, Shanxi, China

  • Tianjin Chest Hospital

    Tianjin, Tianjin Municipality, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.